Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

GENELUX Corp Director's Dealing 2026

Jan 7, 2026

33857_dirs_2026-01-07_cca43532-4450-4070-bfc9-c431eab19d72.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: GENELUX Corp (GNLX)
CIK: 0001231457
Period of Report: 2026-01-02

Reporting Person: Litten Jason (Chief Medical Officer)

More from GENELUX Corp

Annual Report 2026
Apr 29
Proxy Solicitation & Information Statement 2026
Apr 29
Director's Dealing 2026
Mar 26
Director's Dealing 2026
Mar 26
Director's Dealing 2026
Mar 26
Director's Dealing 2026
Mar 26
Capital/Financing Update 2026
Mar 19
Capital/Financing Update 2026
Mar 19
Capital/Financing Update 2026
Mar 19
Director's Dealing 2026
Mar 4
View all filings →